JPRN-UMIN000024146
Completed
未知
Can fecal calprotectin be a predictive marker for refractoriness in patients with ulcerative colitis ? - Fecal calprotectin for refractory ulcerative colitis
Showa University, School of Medicine0 sites100 target enrollmentNovember 1, 2016
Conditionslcerative colitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- lcerative colitis
- Sponsor
- Showa University, School of Medicine
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are willing to recieve topical therapies, not willing to samlple feces and regular users of non\-steroidal antiinflammatory drugs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54
Active, not recruiting
Not Applicable
Does measurement of fecal calprotectin levels help distinguish various colitis?Diseases of the digestive systemKCT0003598Eulji University Hospital30
Recruiting
Not Applicable
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot studycolitis10017966NL-OMON42995ederlands Kanker Instituut50
Not yet recruiting
Not Applicable
Fecal calprotectin as a predictive factor of relapse in patients with ulcerative colitis treated with tacrolimus : A prospective studyJPRN-UMIN000014714Shimane University Hospital50
Recruiting
Not Applicable
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50